clinical trial · NCT07106723
Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL
Institute of Hematology & Blood Diseases Hospital, China·phase2·recruiting·n = 50
CD7 PositiveT - Cell LymphomaASCT+CD7-CART
brief summary
To evaluate the safety and efficacy of autologous hematopoietic stem cell transfer (ASCT) combined with CD7-CART in the treatment of CD7+ TCL
started
Jun 1, 2025
primary completion
Jan 7, 2029
completion
Jan 7, 2030
last updated
Aug 6, 2025
official title
A Clinical Study of the Safety and Efficacy of Autologous Hematopoietic Stem Cell Transplantation in Combination With CD7-CART in the Treatment of CD7+ T-Cell Lymphoma
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol